Jaguar Health, Inc. (JAGX) Stock Forecast
JAGX analyst forecast
as of October 18, 2026- Analyst consensus
- —
- Price target
- $262.50 average of analyst targets
- Upside to target
- +7,346.8% from the latest close
- Next earnings
- November 13, 2026
- 52-week range
- $2.67 – $1,155.00
JAGX price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
JAGX earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current fiscal year (2026) | −$4.20 | −$4.20 | −$4.20 | −$803.95 | +99.5% | 1 |
| Next fiscal year (2027) | −$9.45 | −$9.45 | −$9.45 | −$4.20 | −125.0% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
JAGX revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current fiscal year (2026) | $0 | $0 | $0 | +77.8% | — |
| Next fiscal year (2027) | $14.1M | $14.1M | $14.1M | −31.0% | 1 |
JAGX EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
JAGX revenue: reported and forecast
JAGX EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current fiscal year (2026) | −$109.38 | −$109.38 | −$109.38 | −$109.38 | −$4.20 | −96.2% | 1 up · 0 down |
| Next fiscal year (2027) | −$14.00 | −$14.00 | −$14.00 | −$14.00 | −$9.45 | −32.5% | 1 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
JAGX earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; JAGX beat in 6 of 12.
What analysts expect from JAGX
The average price target is $262.50, 7,346.8% above the latest close of $3.52. Analysts expect earnings of −$4.20 per share for 2026, +99.5% from a year earlier. For 2027 the average estimate is −$9.45 per share on revenue of $14.1 million. Jaguar Health beat the EPS estimate in 6 of the last 12 quarters.
Related: JAGX income statement, JAGX key metrics, JAGX chart. See the JAGX stock overview for the latest quote and news.
JAGX forecast FAQ
What is Jaguar Health's price target?
The average analyst price target for Jaguar Health is $262.50, 7,346.8% above the latest close of $3.52.
What is Jaguar Health's EPS forecast?
Analysts forecast −$4.20 per share for 2026 (range −$4.20 to −$4.20); for 2027 the estimate is −$9.45.
When does Jaguar Health report earnings?
Jaguar Health is expected to report results for the quarter ending September 30, 2026 on November 13, 2026.
Does Jaguar Health usually beat earnings estimates?
Jaguar Health reported EPS at or above the analyst estimate in 6 of the last 12 quarters.